PCN16 ADDING RITUXIMABTO STANDARD CHEMOTHERAPY APPEARS DOMINANT VS. CHEMOTHERAPY ALONE IN ADVANCED STAGE NHL—INTERIM RESULTS FROM A RANDOMIZED CLINICAL TRIAL (RCT)
Abstract
Authors
K Hieke M Herold
K Hieke M Herold
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now